Central Pacific Bank - Trust Division’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
16,924
+8,487
+101% +$993K 0.22% 111
2026
Q1
$1.01M Buy
8,437
+3,820
+83% +$441K 0.13% 173
2025
Q4
$486K Sell
4,617
-347
-7% -$32.6K 0.06% 293
2025
Q3
$417K Buy
4,964
+3,123
+170% +$257K 0.05% 316
2025
Q2
$146K Buy
1,841
+97
+6% +$7.71K 0.02% 506
2025
Q1
$157K Sell
1,744
-21,643
-93% -$2.02M 0.02% 490
2024
Q4
$2.33M Sell
23,387
-6,100
-21% -$629K 0.3% 74
2024
Q3
$3.35M Sell
29,487
-5,950
-17% -$707K 0.42% 49
2024
Q2
$4.39M Sell
35,437
-2,345
-6% -$302K 0.52% 28
2024
Q1
$4.95M Buy
+37,782
New +$4.66M 0.61% 22

Other funds holding MRK

Central Pacific Bank - Trust Division's MRK Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Merck (MRK) stake by 101% in Q2 2026, buying an estimated $993K and bringing the position to 16,924 shares worth $2.17M. The position accounts for 0.22% of the portfolio, ranked #111.

Central Pacific Bank - Trust Division first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.95M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Central Pacific Bank - Trust Division held 16,924 shares of Merck worth $2.17M as of Q2 2026.
  • Central Pacific Bank - Trust Division bought 8,487 Merck shares in Q2 2026, an estimated $993K.
  • Merck made up 0.22% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #111 holding.
  • Central Pacific Bank - Trust Division first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's Merck position peaked at $4.95M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.